Ketrolac Tromethamine Injection, Solution
NDC Package 83854-021-10
Package Information
Ketrolac Tromethamine (ketorolac tromethamine) injection is a medication used to temporarily relieve itching eyes caused by seasonal allergies. This formulation utilizes a injection, solution delivery system. Marketed by Anthea Pharma Private Limited, this product is identified by NDC 83854-021 and is authorized under FDA application ANDA221041.
Identification & Billing
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 83854 - Anthea Pharma Private Limited
- 83854-021 - Ketrolac Tromethamine
- 83854-021-10 - 10 VIAL in 1 CARTON / 1 mL in 1 VIAL (83854-021-01)
- 83854-021 - Ketrolac Tromethamine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (83854-021). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83854-021-10 identifies a specific commercial package of 10 vial in 1 carton / 1 ml in 1 vial (83854-021-01) of Ketrolac Tromethamine, a human prescription drug labeled by Anthea Pharma Private Limited. This injection, solution is formulated for intramuscular; intravenous use and contains ketorolac tromethamine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Anthea Pharma Private Limited on September 25, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to temporarily relieve itching eyes caused by seasonal allergies. It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling.
How is this Anthea Pharma Private Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83854002110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.